BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Zevra Therapeutics Inc. (NASDAQ:ZVRA)

1 post

Biotech NewsZevra Therapeutics (ZVRA) Poised for Growth After Adding High-Profile Biopharma CEO to Board

  • BioTech Health X
  • December 8, 2025
Zevra Therapeutics Inc. (NASDAQ:ZVRA) is a commercial-stage biopharmaceutical company that has evolved into a recognized leader in the…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • This Biotech Keeps Raising Red Flags — Why Coeptis Therapeutics (COEP) Looks More Like a Warning Than an Opportunity
  • Elevance Health (ELV) Touches Millions Every Day — Yet it Rarely Makes Headlines
  • This 120-Year-Old Pharma Giant Is Suddenly Hot Again — Teva Pharmaceutical (TEVA)
  • From Hospitals to Medicare Dominance: How Humana (HUM) Built a Healthcare Empire
  • This NASDAQ Biotech Is Targeting a $6 Billion Market No One Talks About – Meet Immix Biopharma (IMMX)
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • January 28, 2026
    This Biotech Keeps Raising Red Flags — Why Coeptis Therapeutics (COEP) Looks More Like a Warning Than an Opportunity
    • January 28, 2026
    Elevance Health (ELV) Touches Millions Every Day — Yet it Rarely Makes Headlines
    • January 28, 2026
    This 120-Year-Old Pharma Giant Is Suddenly Hot Again — Teva Pharmaceutical (TEVA)
    • January 28, 2026
    From Hospitals to Medicare Dominance: How Humana (HUM) Built a Healthcare Empire
    • January 28, 2026
    This NASDAQ Biotech Is Targeting a $6 Billion Market No One Talks About – Meet Immix Biopharma (IMMX)
Recent Posts
  • Cingulate (CING) Is Betting Big on ADHD — But Is it Running Out of Time?
    • January 28, 2026
  • Here’s Why UnitedHealth Group (UNH) Keeps Winning While Healthcare Keeps Changing
    • January 28, 2026
  • This Biotech Is Trying to Teach the Immune System to Fight Cancer — Inside BriaCell Therapeutics Corp (BCTX)
    • January 28, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (746)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top